When was TrueCath founded?

TrueCath was founded in 2018 and raised its 1st funding round within a year of its incorporation.

Where is TrueCath located?

TrueCath is headquartered in Camarillo, United States.

Is TrueCath a funded company?

TrueCath is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 21, 2018.

When was the latest funding round of TrueCath?

TrueCath's latest funding was a $***** Grant (prize money) round on Aug 01, 2019, with participation from 1 investor. Its primary sector is Hospital Equipment. Globally, the Hospital Equipment sector has seen $9.15M in funding in 2026 to date.

Where does TrueCath rank among its competitors?

TrueCath ranks 78th amongst 72 active competitors, of which 13 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was 410 Medical, which secured $14M in Mar, 2025.

Who are the top competitors of TrueCath?

TrueCath's top competitors include 410 Medical, IRadimed and KORU Medical Systems. Among them, 410 Medical secured the most recent funding round in March, 2025.

TrueCath - 2026 Company Profile, Funding & Competitors

TrueCath is a deadpooled company based in Camarillo (United States), founded in 2018. It operates as a Developer of auto-catheter IV devices. TrueCath has raised an undisclosed amount in funding. The company has 72 active competitors, including 13 funded and 12 that have exited. Its top competitors include companies like 410 Medical, IRadimed and KORU Medical Systems.

Company Details

Developer of auto-catheter IV devices. It eliminates the need for advanced training or expensive IV teams, and its added functionality integrates seamlessly into the current clinical workflow without any additional equipment or procedures.

Key Metrics

Founded Year

2018

Location

Camarillo, United States

Stage

Deadpooled

Latest Funding Round

Grant (prize money), Aug 01, 2019, $*****

Investors

HHS

Ranked

78^th among 93 competitors

Similar Companies

410 Medical & 82 more

View TrueCath's full profile

TrueCath has raised funding over 2 rounds. Its first funding round was on Sep 21, 2018. Its latest funding round was a Grant (prize money) round on Aug 01, 2019 for $*****. 1 investor participated in its latest round. TrueCath has 1 institutional investor.

Here is the list of recent funding rounds of TrueCath:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 01, 2019	4708277	Grant (prize money)	6597410	5292166	6717261	7948800
Sep 21, 2018	1411000	Grant (prize money)	5061011	8590921	7683968	HHS

Access funding benchmarks and valuations. Sign up today!

View details of TrueCath's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of TrueCath include 410 Medical, IRadimed and KORU Medical Systems. Here is the list of Top 10 competitors of TrueCath, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	410 Medical 2012, Durham (United States), Series B	Provider of rapid infusion system for critically ill patients	$66M	Hatteras Venture Partners, Bios Partners ... & 18 others	57/100
2nd	IRadimed 2004, Winter Springs (United States), Public	MRI patient care solutions: monitors, infusion pumps, and metal detectors	$1.5M	-	60/100
3rd	KORU Medical Systems 1980, City of Orange (United States), Public	Manufacturer of infusion systems and accessories for subcutaneous drug administration	-	-	56/100
4th	Belmont Medical Technologies 1980, Billerica (United States), Acquired	Fluid warming and temperature regulation devices for critical care	-	Five Points Capital, Quilvest Capital Partners	53/100
5th	Hospira 2004, Lake (United States), Acquired	Manufacturer of injectable drugs, infusion technologies and biosimilars	-	NovaQuest Capital Management	44/100
6th	Lineus Medical 2015, Fayetteville (United States), Series B	Provider of an I.V. dislodgement prevention device	$6.4M	Hartford HealthCare, MB Venture Partners & 6 others	41/100
7th	Ivenix 2001, Amesbury (United States), Acquired	Smart infusion system for guided workflows, adaptive delivery, and secondary delivery	$160M	6 Dimensions Capital, F-Prime Capital & 5 others	40/100
8th	Eitan Medical 2015, Netanya (Israel), Acquired	Developer of smart wearable devices for drug delivery	-	-	39/100
9th	CRISI Medical Systems 2009, San Diego (United States), Acquired	Medication management system for IV delivery	-	EvoNexus, Tigris Ventures & 5 others	39/100
10th	Eurozyto 2013, Frankfurt Am Main (Germany), Funding Raised	Developer of infusion and injection solutions for patient care	-	-	38/100
78th	TrueCath 2018, Camarillo (United States), Deadpooled	Developer of auto-catheter IV devices	-	HHS	15/100